The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2018 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis

CITE Title : CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis Personal Author(s) : Ford, Nathan;Shubber, Zara;Jarvis, Joseph N;Chiller, Tom;Greene, Greg;Migone, Chantal;Vitoria, Marco;Doherty, Meg;Meintjes, Graeme; Published Date : Mar 04 2018 Source : Clin Infect Dis. 2018; 66(Suppl 2):S152-S159. URL : https://stacks.cdc.gov/view/cdc/52788 Ford, Nathan et al. (2018). CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis. 66 Ford, Nathan et al. "CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis" 66 (2018) Ford, Nathan et al. "CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis" vol. 66, 2018 Export RIS Citation Information.

:

Ford, Nathan ;

Shubber, Zara

Mar 04 2018 | Clin Infect Dis. 2018; 66(Suppl 2):S152-S159.

:

BackgroundCurrent guidelines recommend screening all people living with human immunodeficiency virus (PLHIV) who have a CD4 count ≤100 cells/µL for...
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial

CITE Title : Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial Personal Author(s) : Meya, David B.;Kiragga, Agnes N.;Nalintya, Elizabeth;Morawski, Bozena M.;Rajasingham, Radha;Park, Benjamin J.;Mubiru, Anthony;Kaplan, Jonathan E.;Manabe, Yukari C.;Boulware, David R.; Published Date : Feb 01 2019;2-1-; Source : J Acquir Immune Defic Syndr. 2018; 80(2):182-189 URL : https://stacks.cdc.gov/view/cdc/77380 Meya, David B. et al. (2019). Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. 80(2). Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" 80, no. 2 (2019) Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" vol. 80, no. 2, 2019 Export RIS Citation Information.

:

Meya, David B. ;

Kiragga, Agnes N.

Feb 01 2019 | J Acquir Immune Defic Syndr. 2018; 80(2):182-189

:

Background:HIV-infected persons with cryptococcal antigenemia (CrAg) are at high risk for meningitis or death. We evaluated the effect of CrAg screeni...